Literature DB >> 21533967

Use of laparoscopy as an alternative to computed tomography (CT) and positron emission tomography (PET) scans for the detection of recurrence in patients with gastric cancer: a pilot study.

Jung Ho Shim1, Han Mo Yoo, Han Hong Lee, Jun Gi Kim, Hae Myung Jeon, Kyo Young Song, Cho Hyun Park.   

Abstract

BACKGROUND: This study aimed to evaluate laparoscopy as a diagnostic method for detecting recurrence in patients with advanced gastric cancer.
METHODS: Diagnostic laparoscopy was performed for 12 patients with insufficient evidence of intraabdominal gastric cancer recurrence by computed tomography or positron emission tomography. By comparing laparoscopic observations with conventional radiologic results, the diagnostic accuracy of laparoscopy was assessed.
RESULTS: In 11 (92%) of 12 cases of recurrence not diagnosed by imaging studies, laparoscopic examination confirmed the case as a recurrence. Using diagnostic laparoscopy, retroperitoneal lymph node recurrence was confirmed in two patients, peritoneal seeding nodules in five patients, and recurrent masses invading the mesocolon in two patients. Two patients had no definitive recurrence grossly but were confirmed as recurrence cases by washing cytology during the laparoscopic procedure. One patient had a duodenal stump recurrence. No patients experienced operation-related morbidity.
CONCLUSION: Laparoscopy is a safe and feasible method for detecting recurrence with acceptable accuracy. This approach provides more accurate information than conventional imaging methods.

Entities:  

Mesh:

Year:  2011        PMID: 21533967     DOI: 10.1007/s00464-011-1722-1

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  18 in total

1.  Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer.

Authors:  Y Maehara; S Hasuda; T Koga; E Tokunaga; Y Kakeji; K Sugimachi
Journal:  Br J Surg       Date:  2000-03       Impact factor: 6.939

2.  Clinical outcomes with laparoscopic stage M1, unresected gastric adenocarcinoma.

Authors:  Abeezar I Sarela; Thomas J Miner; Martin S Karpeh; Daniel G Coit; David P Jaques; Murray F Brennan
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

3.  Treatment results for gastric cancer surgery: 12 years' experience at a single institute in Korea.

Authors:  C H Park; K Y Song; S N Kim
Journal:  Eur J Surg Oncol       Date:  2007-04-17       Impact factor: 4.424

4.  The role of surgery in the treatment of recurrent gastric cancer.

Authors:  Kyo-Young Song; Seung-Man Park; Seung-Nam Kim; Cho-Hyun Park
Journal:  Am J Surg       Date:  2008-04-16       Impact factor: 2.565

5.  Recent advances in surgical treatment have improved the survival of patients with gastric carcinoma.

Authors:  E Otsuji; T Yamaguchi; K Sawai; A Hagiwara; H Taniguchi; T Takahashi
Journal:  Cancer       Date:  1998-04-01       Impact factor: 6.860

6.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

7.  The role of laparoscopy in second-look evaluations for ovarian cancer.

Authors:  A Husain; D S Chi; M Prasad; N Abu-Rustum; R R Barakat; C L Brown; E A Poynor; W J Hoskins; J P Curtin
Journal:  Gynecol Oncol       Date:  2001-01       Impact factor: 5.482

8.  S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Authors:  Wasaburo Koizumi; Hiroyuki Narahara; Takuo Hara; Akinori Takagane; Toshikazu Akiya; Masakazu Takagi; Kosei Miyashita; Takashi Nishizaki; Osamu Kobayashi; Wataru Takiyama; Yasushi Toh; Takashi Nagaie; Seiichi Takagi; Yoshitaka Yamamura; Kimihiko Yanaoka; Hiroyuki Orita; Masahiro Takeuchi
Journal:  Lancet Oncol       Date:  2008-02-20       Impact factor: 41.316

9.  Detecting recurrence of gastric cancer: the value of FDG PET/CT.

Authors:  Min Jung Park; Won Jae Lee; Hyo K Lim; Ko Woon Park; Joon Young Choi; Byung-Tae Kim
Journal:  Abdom Imaging       Date:  2009-07

10.  A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients.

Authors:  F De Vita; M Orditura; E Matano; R Bianco; C Carlomagno; S Infusino; V Damiano; E Simeone; M R Diadema; E Lieto; P Castellano; S Pepe; S De Placido; G Galizia; N Di Martino; F Ciardiello; G Catalano; A R Bianco
Journal:  Br J Cancer       Date:  2005-05-09       Impact factor: 7.640

View more
  5 in total

1.  At which stage of gastric cancer progression do levels of carcinoembryonic antigen and carbohydrate antigen 19-9 increase? Application in advanced gastric cancer treatment.

Authors:  Eui Soo Han; Han Hong Lee; Jun Suh Lee; Kyo Young Song; Cho Hyun Park; Hae Myung Jeon
Journal:  J Gastric Cancer       Date:  2014-06-30       Impact factor: 3.720

2.  Survival benefit of palliative gastrectomy in gastric cancer patients with peritoneal metastasis.

Authors:  Masanori Tokunaga; Masanori Terashima; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Hirofumi Yasui; Narikazu Boku
Journal:  World J Surg       Date:  2012-11       Impact factor: 3.352

Review 3.  Indication of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer (Gastripec, Gastrichip).

Authors:  Beate Rau; Linda Feldbrügge; Felix Gronau; Miguel Enrique Alberto Vilchez; Peter Thuss-Patience; Pierre Emmanuel Bonnot; Olivier Glehen
Journal:  Visc Med       Date:  2022-02-23

4.  Clinicopathologic characteristics and prognostic factors of 63 gastric cancer patients with metachronous ovarian metastasis.

Authors:  Qiang Feng; Wei Pei; Zhao-Xu Zheng; Jian-Jun Bi; Xing-Hua Yuan
Journal:  Cancer Biol Med       Date:  2013-06       Impact factor: 4.248

5.  Evaluation of the recurrence pattern of gastric cancer after laparoscopic gastrectomy with D2 lymphadenectomy.

Authors:  Yuichiro Kawamura; Seiji Satoh; Yusuke Umeki; Yoshinori Ishida; Koichi Suda; Ichiro Uyama
Journal:  Springerplus       Date:  2016-06-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.